About this trial
This nationwide, multicenter observational study will establish and improve a hospital-based clinical surveillance and early warning system for respiratory syndrome pathogens. Clinical data and biospecimens generated during routine care will be collected from participating medical institutions every two weeks to monitor pathogen trends, support risk assessment, and provide evidence for prevention and control measures.
Eligibility criteria
Qualifiers
Patients with respiratory syndrome: Eligible patients are those diagnosed with respiratory syndrome based on the predefined data dictionary and the following ICD-10 (International Statistical Classification of Diseases, 10th Revision) diagnosis codes: R05, R50, J00, J01, J02, J03, J04, J06, J07, J08, J09, J10, J11, J12, J13, J14, J15, J16, J17, J18, J20, J21, J98.414, and J98.802.
Medical history (History of Present Illness): Positive test result for a respiratory syndrome-related pathogen.
Laboratory testing: Positive test result for a respiratory syndrome-related pathogen.
Diagnosis: Diagnosis containing the term "respiratory tract infection."
Disqualifiers
Participants who may compromise the study results: Patients who are unable to provide a specimen or whose specimen volume is insufficient for laboratory testing.
Participants who are unable to comply with study procedures.
Trial design
Treatments tested in this trial
- Tiered pathogen testing and multi-omics analysis